ESGO eAcademy, The Official eLearning Portal of the European Society of Gynaecological Oncology

Create Account Sign In
Sign in to view your progression
ON-DEMAND
Mechanisms of resistance to PARPi in ovarian cancer
ON-DEMAND
Chemotherapy options after progression to PARPi
ON-DEMAND
New options of therapy in patients resistant to PARPi
Q&A
Q&A

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies